Publications by authors named "H S Dhooria"
Article Synopsis
- ABD is increasingly common in adults with chronic kidney disease, prompting a study to compare low calcium dialysate (LCD) and high calcium dialysate (HCD) effects on bone health.
- Forty patients with specific pre-dialysis hormone levels were divided into LCD and HCD groups for a 6-month study, showing no significant initial differences between them.
- Results indicated that LCD led to increased bone turnover markers and higher overall bone parameters compared to HCD, suggesting that LCD could be a beneficial treatment for patients with dynamic bone disease.
Background And Objectives: Diabetes mellitus is associated with poor clinical outcomes in patients with coronavirus disease 2019 (COVID-19). This study aimed to explore the clinical characteristics of patients with type 2 diabetes with COVID-19, and to determine the impact of type 2 diabetes on clinical outcome of patients with COVID-19.
Material And Methods: This single-center, retrospective, observational study enrolled patients admitted from March 2020 to June 2021 with COVID-19.
Background: Coronavirus disease-2019 (COVID-19) infection and thrombosis are of great clinical importance as this association has shown to increase mortality. We intend to estimate the incidence of thrombotic events (TE) and their impact on clinical outcomes in hospitalized COVID-19 patients.
Methods: This was an analytical cross-sectional study.
Article Synopsis
- - India faced a severe second wave of COVID-19, with challenges managing the disease due to medication shortages; tocilizumab and high-dose steroids have shown efficacy, but their comparison was lacking.
- - This study analyzed 336 patients with severe COVID-19, comparing the effects of intravenous tocilizumab and Methylprednisolone Pulse while both groups received standard care, assessing outcomes after 30 days.
- - Results indicated that although tocilizumab reduced the need for invasive ventilation compared to Methylprednisolone (17% vs. 29%), there was no significant difference in mortality rates after 30 days (36% vs. 34%), suggesting further research is needed.
Evaluation of Health-Related Quality of Life in Adult Patients on Hemodialysis.
Int J Appl Basic Med Res
November 2021
Background: Hemodialysis in end-stage renal disease patients causes disability in different domains of patient's lives, leading to impaired (quality of life [QOL]). Studies measuring the QOL in patients on renal replacement therapy are limited in the Indian scenario.
Aims: To evaluate the QOL in adult patients on maintenance hemodialysis by applying the World Health Organization QOL (WHOQOL)-BREF scale.